Stay updated on ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial
Sign up to get notified when there's something new on the ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial page.

Latest updates to the ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial page
- ChecktodayChange DetectedDifference0.3%

- Check7 days agoChange DetectedA new revision entry 'v3.6.6' was added to the study record history, and the previous revision 'v3.6.5' was removed, representing a software version update in the page's history.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedA new revision entry 'Revision: v3.6.5' was added to the record history, and the previous 'Revision: v3.6.4' entry was removed. This update reflects the page's revision tracking activity rather than changes to the study data.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision label updated from v3.6.3 to v3.6.4, signaling a backend/UI update to the page. This change does not alter study data or content.SummaryDifference0.1%

- Check50 days agoChange DetectedA new Study Status entry was added to the record history, reflecting an update to the trial's status. An older 2026-06-11 history item was removed.SummaryDifference0.3%

- Check64 days agoChange DetectedThe Record History gains a new entry for Revision: v3.6.3. This signals a subsequent update to the study record's metadata on ClinicalTrials.gov.SummaryDifference0.1%

Stay in the know with updates to ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial page.